# Next-Gen HIV Genotyping for 28 Antiretroviral Drugs

**ID:** RES-004
**Year:** 2024
**Source:** CID
**Link:** [https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf458/8237671](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf458/8237671)

---

## Abstract

Design and evaluation of comprehensive genotyping assay detecting resistance to 28 ARVs across 5 drug classes including lenacapavir.

---

## Key Concepts

- Primary research focus from 2023-2025 HIV literature
- Relevant to understanding HIV biology, treatment, or prevention
- Contributes to the broader HIV research landscape

---

## Relevance to Project

This paper contributes to the Ternary VAE bioinformatics project by providing context on:
- HIV sequence evolution and variability
- Biological constraints on viral fitness
- Therapeutic targets and resistance mechanisms

---

*Added: 2025-12-24*
